Amp Capital Investors LTD Grifols Sa Transaction History

Amp Capital Investors LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$15.4 - $20.16 $3.86 Million - $5.05 Million	-250,463 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $310,244 - $364,843	-17,009 Reduced 6.36%	250,463 $4.67 Million
Q1 2020 May 13, 2020	SELL	$16.28 - $25.63 $640,829 - $1.01 Million	-39,363 Reduced 12.83%	267,472 $5.51 Million
Q3 2019 Nov 13, 2019	BUY	$19.85 - $22.76 $1.51 Million - $1.73 Million	76,135 Added 33.0%	306,835 $6.18 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $145,293 - $174,286	8,260 Added 3.71%	230,700 $4.75 Million
Q1 2019 May 15, 2019	SELL	$18.01 - $20.11 $375,454 - $419,233	-20,847 Reduced 8.57%	222,440 $4.24 Million
Q4 2018 Feb 13, 2019	BUY	$17.44 - $21.53 $3.25 Million - $4.01 Million	186,115 Added 325.54%	243,287 $4.39 Million
Q3 2018 Nov 13, 2018	BUY	$19.97 - $21.96 $734,536 - $807,732	36,782 Added 180.39%	57,172 $1.22 Million
Q2 2018 Aug 13, 2018	BUY	$20.16 - $24.68 $411,062 - $503,225	20,390 New	20,390 $438,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.